Chemical Engineering of Mesenchymal Stem Cells to Induce a Cell Rolling Response-Reference-Cited by-同舟云学术

Chemical Engineering of Mesenchymal Stem Cells to Induce a Cell Rolling Response

Published:2008-10-31 Issue:11 Volume:19 Page:2105-2109
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Sarkar Debanjan¹,Vemula Praveen Kumar¹,Teo Grace S. L.¹,Spelke Dawn¹,Karnik Rohit¹,Wee Le Y.¹,Karp Jeffrey M.¹

Affiliation:

1. Harvard-MIT Division of Heath Sciences and Technology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, 65 Landsdowne Street, and Department of Mechanical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc800345q

Reference33 articles.

1. Will regulation be the death of cell therapy in the United States?

2. The therapeutic potential of mesenchymal stem cells

3. Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases

4. A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction

5. Adult Bone Marrow–Derived Cells for Cardiac Repair

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical Coaxing of Mesenchymal Stromal Cells by Drug Repositioning for Nestin Induction;International Journal of Molecular Sciences;2024-07-23

2. Bioengineered Mesenchymal Stem/Stromal Cells in Anti-Cancer Therapy: Current Trends and Future Prospects;Biomolecules;2024-06-21

3. DNA‐Based Cell Surface Engineering for Programming Multiple Cell–Cell Interactions;DNA Nanotechnology for Cell Research;2024-05-03

4. Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer;Molecular Therapy: Oncology;2024-03

5. Surface Engineering of Natural Killer Cells with CD44‐targeting Ligands for Augmented Cancer Immunotherapy;Small;2023-12-31